Skip to main content
Equibles
BAX logo

BAX · Baxter International Inc

Track BAX — free Ask ALVIS about BAX
$22.40 +0.73 (+3.37%) At close · Jul 24
Market Cap
$11.57B
Shares
516.47M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$22.40 Open$21.95 Day$21.92–22.64 52W$15.73–29.12 Avg vol 30d5.9M Short int36.8M · 7.1% float · 6.5d Short vol59% Last earningsJul 30, 2026 DataJan 2020–Jul 2026 Filing10-Q · Apr 30

Up next

Next earnings call
Jul 30, 2026 Scheduled · in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Apr 30, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Weak Quant / Vol Very High
      Market backdrop VIX 18.6 · elevated Equity put/call 0.79
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +15%
      above
      Price vs 50-day avg +9%
      above
      RSI (14) 56
      neutral
      MACD trend Negative
      52-week position 50%
      mid-range
      Momentum
      relative strength
      Very Strong
      1-month return +4%
      trailing
      6-month return +12%
      trailing
      YTD return +17%
      this year
      Relative strength +5%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $21 › 200d $20 — 50d above 200d
      Institutional flow Accumulating
      181 of 666 funds reported for Jun 30 · net +351.7K sh shares · +28 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      7.13% of float · ▼ -4.5% MoM · 6.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      666 holders — near 3-yr low, contrarian setup
      Squeeze score 83
      high risk · 0–100
      Fundamentals
      Weak
      Revenue growth +6%
      Y/Y
      Gross margin 30%
      contracting
      EPS growth −47%
      Y/Y
      Buyback $1.3B
      remaining
      Balance sheet $7.5B
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 47%
      annualized · 1-yr
      Max drawdown −45%
      past year
      ATR 3.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Apr 30, 2026
      Reported sales growth from continuing operations · Full-Year 2026 Initiated 0% – 1%
      Adjusted earnings from continuing operations per diluted share · Full-Year 2026 Initiated $1.85 – $2.05

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +15% Bullish
      Price vs 50-day avg
      +9% Bullish
      RSI (14)
      56 Neutral
      MACD trend
      Negative Bearish
      52-week position
      50% Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $21 › 200d $20 — 50d above 200d
      Institutional flow Accumulating
      181 of 666 funds reported for Jun 30 · net +351.7K sh shares · +28 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      7.13% of float · ▼ -4.5% MoM · 6.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      666 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      52-wk low $16 Now $22 · 50% 52-wk high $29
      vs 200-day avg +15% vs 50-day avg +9%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      BAX
      Baxter International Inc
      this stock
      		$11.57B +17.3% +5.7% — 7.1%
      ISRG
      Intuitive Surgical Inc
      		 $119.23B -41.4% +20.5% 38.8 1.9%
      MDLN
      Medline Inc.
      		 $50.91B -7.7% +11.5% — 2.2%
      BDX
      Becton Dickinson & Co
      		 $43.08B +1.6% +8.2% 59.4 3.8%
      ALC
      Alcon Inc
      		 $33.12B -14.7% +10.5% — 2.7%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      679
      % held
      99.5%
      Reported
      181 of 666
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      475
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      36.8M
      Days to cover
      6.5d
      Change
      -1.7M sh
      View
      Short Volume
      Short vol %
      59%
      As of
      Jul 24, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      18
      Value
      $396
      As of
      Jun 30, 2026
      View
      Off-Exchange
      Off-exchange %
      36.0%
      Week of
      Jun 29, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Lisa McClain
      Amount
      $1.0K–$15.0K
      Traded
      Oct 31, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $11.2B
      Net income (FY)
      $-957.0M
      EPS diluted
      $-1.87
      View
      Buybacks
      Authorized
      $300.0M
      Remaining
      $1.3B
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 14, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $645.2K
      Shares
      36.3K
      Filed
      May 18, 2026
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Jul 30, 2026
      Last call
      Jun 9, 2026
      View
      Investor Relations
      Latest news
      Baxter to Host Second-Quarter 202…
      Published
      Jul 9, 2026
      Upcoming events
      2
      View

      Performance

      5D 20D 120D MTD YTD
      BAX -0.9% +3.9% +11.7% +5.1% +17.3%
      SPY -1.7% +0.7% +6.4% -1.2% +8.3%
      vs SPY +0.7% +3.3% +5.3% +6.2% +9.0%

      Capital returns

      Latest dividend
      $0.01 / share · ex May 29, 2026
      Cut 94.1%
      Paid (TTM)
      $0.20 / share · 4 payouts
      Dividend yield (TTM, derived)
      0.89%
      Buyback program · as of Mar 31, 2026
      Authorized
      $300.00M
      Spent (derived)
      —
      Remaining
      $1.30B

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 10456 CUSIP 071813109 13F (30d) 169 filings 168 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)